Brendan Smith
Stock Analyst at TD Cowen
(1.76)
# 3,379
Out of 5,140 analysts
16
Total ratings
45.45%
Success rate
1.46%
Average return
Main Sectors:
Stocks Rated by Brendan Smith
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DNA Ginkgo Bioworks Holdings | Maintains: Buy | $14 → $12 | $9.22 | +30.15% | 2 | Jan 8, 2026 | |
| TWST Twist Bioscience | Maintains: Buy | $32 → $43 | $48.59 | -11.50% | 1 | Jan 8, 2026 | |
| SLP Simulations Plus | Maintains: Hold | $16 → $19 | $11.66 | +62.95% | 2 | Jan 8, 2026 | |
| SDGR Schrödinger | Maintains: Buy | $33 → $24 | $11.53 | +108.15% | 1 | Jan 8, 2026 | |
| CTKB Cytek Biosciences | Maintains: Buy | $4 → $5 | $4.43 | +12.87% | 1 | Jan 8, 2026 | |
| AZTA Azenta | Maintains: Hold | $35 → $39 | $29.28 | +33.20% | 1 | Jan 8, 2026 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $79 → $90 | $70.98 | +26.80% | 3 | Jan 8, 2026 | |
| NVAX Novavax | Maintains: Hold | $8 → $7 | $9.20 | -23.91% | 2 | Nov 4, 2025 | |
| WST West Pharmaceutical Services | Initiates: Buy | $350 | $241.12 | +45.16% | 1 | Oct 29, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Outperform | n/a | $63.59 | - | 1 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $20.19 | - | 1 | Dec 5, 2022 |
Ginkgo Bioworks Holdings
Jan 8, 2026
Maintains: Buy
Price Target: $14 → $12
Current: $9.22
Upside: +30.15%
Twist Bioscience
Jan 8, 2026
Maintains: Buy
Price Target: $32 → $43
Current: $48.59
Upside: -11.50%
Simulations Plus
Jan 8, 2026
Maintains: Hold
Price Target: $16 → $19
Current: $11.66
Upside: +62.95%
Schrödinger
Jan 8, 2026
Maintains: Buy
Price Target: $33 → $24
Current: $11.53
Upside: +108.15%
Cytek Biosciences
Jan 8, 2026
Maintains: Buy
Price Target: $4 → $5
Current: $4.43
Upside: +12.87%
Azenta
Jan 8, 2026
Maintains: Hold
Price Target: $35 → $39
Current: $29.28
Upside: +33.20%
Halozyme Therapeutics
Jan 8, 2026
Maintains: Buy
Price Target: $79 → $90
Current: $70.98
Upside: +26.80%
Novavax
Nov 4, 2025
Maintains: Hold
Price Target: $8 → $7
Current: $9.20
Upside: -23.91%
West Pharmaceutical Services
Oct 29, 2025
Initiates: Buy
Price Target: $350
Current: $241.12
Upside: +45.16%
Arrowhead Pharmaceuticals
Jul 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $63.59
Upside: -
Dec 5, 2022
Initiates: Outperform
Price Target: n/a
Current: $20.19
Upside: -